| 前收市價 | 2.7500 |
| 開市 | 2.5900 |
| 買盤 | 2.6000 |
| 賣出價 | 3.0000 |
| 拍板 | 30.00 |
| 到期日 | 2024-07-19 |
| 今日波幅 | 2.3700 - 2.6000 |
| 合同範圍 | 無 |
| 成交量 | |
| 未平倉合約 | 5.26k |
InvestorPlaceThe 3 Best Biotech Stocks to Buy in June 2024
The biotech sector, under the life sciences umbrella, exited 2023 with 41 bankruptcies. This was not surprising given the disparity between biotech’s high-capital requirements and rising interest rates set by the Fed. Despite these challenges, some of the best biotech stocks show promise and resilience in a volatile market environment. At the same time, smaller biotech deals became prevalent, accounting for $17 billion during 2023, per JP Morgan data. Another noticeable trend was the uptick in m
Investor's Business DailyBridgeBio Stock Gives Up Gains On Comparisons To BioMarin Drug
BridgeBio stock gave up gains midday Tuesday after releasing a Phase 2 study on a growth disorder treatment.
InvestorPlace7 Biotech Stocks to Put on Your Breakthrough Radar
For those seeking to decipher best speculative opportunities in the market, biotech stocks with breakthrough potential may offer plenty of firepower. Let’s get some of the bad stuff out of the way first. Biotech stocks – even the established players – can be volatile. A miss in the clinical process to commercialize a therapeutic could lead to significant losses. And there’s really no way of reliably forecasting such outcomes. Plus, the sector isn’t always known for delivering predictable financi
